Propeller Health Closes $21.5M Series C
Propeller Health announced today that it completed a $21.5 million Series C financing round. According to a release, the funds will be used to expand the company’s digitally guided therapy…
Propeller Health announced today that it completed a $21.5 million Series C financing round. According to a release, the funds will be used to expand the company’s digitally guided therapy…
Exact Sciences’ Cologuard continues to expand its coverage as it is now included under TRICARE’s preventive services policies, the company announced today. TRICARE provides benefits to 9.4 million active-duty, reserve and…
Exact Sciences’ Cologuard is now included in the 2017 Healthcare Effectiveness Data and Information Set (HEDIS) quality measures for colorectal cancer screening, the organization announced recently. “Cologuard’s inclusion in the…
SHINE Medical Technologies announced this week that it is moving its headquarters from Monona, Wis., to Janesville, Wis., later this year. According to a release, all of SHINE’s employees will…
Cellectar Biosciences’ CLR 131, its lead therapeutic compound, will be used in a University of Wisconsin study of neck and head cancers, the organization announced today. According to a release,…
Cellular Dynamics International announced today that it has created Therapeutics and Life Science business units to better serve its customers. “CDI and Fujifilm are firmly committed to the long-term potential of…
BioTechnique, a specialty drug aseptic fill-finish contract manufacturing organization, will launch a second phase of manufacturing in partnership with a major, international not-for-profit organization, the company announced recently. “We are very…
The Centers for Medicare and Medicaid Services (CMS) announced recently that patients with Medicare Advantage plans must include coverage of Exact Sciences’ Cologuard every three years without cost sharing. “The…
Exact Sciences continues to expand its coverage of Cologuard as Health Care Service Corp (HCSC) and Florida Blue recently updated their medical policies to cover the noninvasive stool DNA screen…
Story provided by Polo Rocha, WisBusiness.com Madison-based EyeKor is planning an expansion of its platform after closing a $600,000 fundraising round. The company, which disclosed the news in an SEC filing,…